Echo Therapeutics Inc (ECTE) financial statements (2020 and earlier)

Company profile

Business Address 99 WOOD AVENUE SOUTH
ISELIN, NJ 08830
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 0184
Cash and cash equivalents 0184
Prepaid expense and other current assets0
Other undisclosed current assets 0111
Total current assets: 0295
Noncurrent Assets
Property, plant and equipment  112
Intangible assets, net (including goodwill)  101010
Intangible assets, net (excluding goodwill)  101010
Deposits noncurrent assets    0
Deferred costs   31
Other noncurrent assets 000
Other undisclosed noncurrent assets 0(1)(1)1
Total noncurrent assets: 0101213
Other undisclosed assets 0112
TOTAL ASSETS: 1132320
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 3324
Accounts payable 2212
Accrued liabilities 1112
Debt   00
Derivative instruments and hedges, liabilities 0016
Deferred revenue and credits   00
Other undisclosed current liabilities 0   
Total current liabilities: 33410
Noncurrent Liabilities
Long-term debt and lease obligation, including:    0
Other undisclosed long-term debt and lease obligation    0
Liabilities, other than long-term debt 0000
Deferred revenue and credits 0000
Other undisclosed noncurrent liabilities    0
Total noncurrent liabilities: 0000
Total liabilities: 33410
Stockholders' equity
Stockholders' equity attributable to parent, including: (3)101910
Common stock 0000
Additional paid in capital 147137132104
Accumulated deficit (150)(128)(113)(94)
Warrants and rights outstanding   113
Other undisclosed stockholders' equity attributable to parent 00(1)(13)
Total stockholders' equity: (3)101910
TOTAL LIABILITIES AND EQUITY: 1132320

Income statement (P&L) ($ in millions)

9/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Revenue, net  000
Financial services revenue 01  
Gross profit: 0100
Operating expenses (18)(12)(20)(15)
Other undisclosed operating loss (0)(1)  
Operating loss: (18)(12)(20)(15)
Nonoperating income (expense) (5)(3)13
Loss on sale of capital leases, net (5)   
Interest and debt expense (0)(4)(4)0
Loss from continuing operations before income taxes: (22)(19)(23)(12)
Income tax expense (0)(0)  
Net loss: (22)(19)(23)(12)
Other undisclosed net income (loss) attributable to parent 044(0)
Net loss attributable to parent: (22)(15)(19)(12)
Other undisclosed net loss available to common stockholders, basic  (0)(0) 
Net loss available to common stockholders, diluted: (22)(15)(19)(12)

Comprehensive Income ($ in millions)

9/30/2016
TTM
12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net loss: (22)(19)(23)(12)
Comprehensive loss, net of tax, attributable to parent: (22)(19)(23)(12)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: